Loading...
XHKG
0455
Market cap45mUSD
Jul 14, Last price  
0.17HKD
1D
10.00%
1Q
21.32%
Jan 2017
-62.50%
Name

Tianda Pharmaceuticals Ltd

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.67
EPS
Div Yield, %
1.58%
Shrs. gr., 5y
Rev. gr., 5y
0.19%
Revenues
532m
-2.67%
10,112,80515,207,86519,970,01436,303,71056,936,40682,951,039206,346,20197,276,705180,213,975247,173,069139,366,849192,784,764195,538,964361,554,649527,002,819491,475,099474,332,111509,955,045546,693,299532,089,000
Net income
-24m
L-55.79%
-654,2776,483,346-37,067,156-112,916,9372,751,75721,287,09267,426,46543,095,59537,740,06222,049,566-17,941,9696,568,59112,442,26510,007,7562,657,1738,800,206-25,917,806-21,674,768-54,635,863-24,155,000
CFO
-50m
L
-1,335,580-812,0802,564,11916,117,33712,634,21338,744,38451,037,08966,281,588127,901,88057,695,269-16,256,95713,443,86737,179,69058,737,82919,169,440-19,902,305-37,634,821-8,225,59079,114,000-49,757,000
Dividend
Jun 13, 20240.0026 HKD/sh

Profile

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
IPO date
Mar 30, 1992
Employees
820
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
532,089
4.34%
546,693
15.26%
Cost of revenue
561,112
616,838
Unusual Expense (Income)
NOPBT
(29,023)
(70,144)
NOPBT Margin
Operating Taxes
(689)
(4,863)
Tax Rate
NOPAT
(28,334)
(65,282)
Net income
(24,155)
11.44%
(54,636)
110.80%
Dividends
(5,588)
(17,625)
Dividend yield
1.19%
2.02%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
102,170
70,304
Long-term debt
20,174
85,150
Deferred revenue
93
Other long-term liabilities
Net debt
(49,314)
(185,564)
Cash flow
Cash from operating activities
(49,757)
79,114
CAPEX
(49,278)
(24,386)
Cash from investing activities
(69,101)
(12,204)
Cash from financing activities
(57,394)
(28,980)
FCF
49,363
103,598
Balance
Cash
162,442
343,444
Long term investments
9,216
(2,426)
Excess cash
145,054
313,683
Stockholders' equity
227,279
289,580
Invested Capital
560,484
502,088
ROIC
ROCE
EV
Common stock shares outstanding
2,150,042
2,150,042
Price
0.22
-6.44%
0.41
100.50%
Market cap
468,709
-6.44%
870,767
100.50%
EV
419,265
711,614
EBITDA
7,384
(19,895)
EV/EBITDA
56.78
Interest
4,946
7,487
Interest/NOPBT